Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suxian Zhao

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|December 10, 2014
[Transient cortical blindness following toxic liver injury: a case report]Qingshan Zhang, Suxian Zhao, Li Kong, et al.
Frontiers in Immunology|December 29, 2022
Machine learning-based predictive and risk analysis using real-world data with blood biomarkers for hepatitis B patients in the malignant progression of hepatocellular carcinomaYuemin Nan, Suxian Zhao, Xiaoxiao Zhang, et al.
American Journal of Translational Research|July 26, 2021
A correlation analysis of the serum hepcidin concentrations and viral loads in HCV-infected patientsRongqi Wang, Suxian Zhao, Jinghua Du, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|July 3, 2015
[Clinical study on FibroTouch and multi-parameter model for diagnosis of hepatic fibrosis in patients with chronic liver disease]Rongqi Wang, Weiguang Ren, Suxian Zhao, et al.
Molecular Medicine Reports|January 20, 2016
TLR4‑dependent signaling pathway modulation: A novel mechanism by which pioglitazone protects against nutritional fibrotic steatohepatitis in miceJinghua Du, Xuemin Niu, Rongqi Wang, et al.
International Journal of Molecular Medicine|February 9, 2022
Resveratrol ameliorates nutritional steatohepatitis through the mmu‑miR‑599/PXR pathwayLingbo Kong, Xinyu An, Lingxi Hu, et al.
Scientific Reports|November 6, 2015
MiR-146a-5p suppresses activation and proliferation of hepatic stellate cells in nonalcoholic fibrosing steatohepatitis through directly targeting Wnt1 and Wnt5aJinghua Du, Xuemin Niu, Yang Wang, et al.
Frontiers in Pharmacology|October 27, 2025
Identification of galangin as a therapeutic candidate for primary biliary cholangitis via systematic druggable genome-wide Mendelian randomization analysis and experimental validationWeirui Ren, Chuang Zhang, Hanyan Wang, et al.
Environmental Monitoring and Assessment|June 25, 2026
Landfill leakage location based on an induced polarization methodYayu Chen, Shibin Liu, Chaozhi Cai, et al.
International Journal of Molecular Sciences|October 30, 2016
Correction: Ping Meng, et al. Involvement of the Interleukin-23/Interleukin-17 Axis in Chronic Hepatitis C Virus Infection and Its Treatment Responses. Int. J. Mol. Sci. 2016, 17, 1070Ping Meng, Suxian Zhao, Xuemin Niu, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|December 10, 2014
[Transient cortical blindness following toxic liver injury: a case report]Qingshan Zhang, Suxian Zhao, Li Kong, et al.
Frontiers in Immunology|December 29, 2022
Machine learning-based predictive and risk analysis using real-world data with blood biomarkers for hepatitis B patients in the malignant progression of hepatocellular carcinomaYuemin Nan, Suxian Zhao, Xiaoxiao Zhang, et al.
American Journal of Translational Research|July 26, 2021
A correlation analysis of the serum hepcidin concentrations and viral loads in HCV-infected patientsRongqi Wang, Suxian Zhao, Jinghua Du, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|July 3, 2015
[Clinical study on FibroTouch and multi-parameter model for diagnosis of hepatic fibrosis in patients with chronic liver disease]Rongqi Wang, Weiguang Ren, Suxian Zhao, et al.
Molecular Medicine Reports|January 20, 2016
TLR4‑dependent signaling pathway modulation: A novel mechanism by which pioglitazone protects against nutritional fibrotic steatohepatitis in miceJinghua Du, Xuemin Niu, Rongqi Wang, et al.
International Journal of Molecular Medicine|February 9, 2022
Resveratrol ameliorates nutritional steatohepatitis through the mmu‑miR‑599/PXR pathwayLingbo Kong, Xinyu An, Lingxi Hu, et al.
Scientific Reports|November 6, 2015
MiR-146a-5p suppresses activation and proliferation of hepatic stellate cells in nonalcoholic fibrosing steatohepatitis through directly targeting Wnt1 and Wnt5aJinghua Du, Xuemin Niu, Yang Wang, et al.
Frontiers in Pharmacology|October 27, 2025
Identification of galangin as a therapeutic candidate for primary biliary cholangitis via systematic druggable genome-wide Mendelian randomization analysis and experimental validationWeirui Ren, Chuang Zhang, Hanyan Wang, et al.
Environmental Monitoring and Assessment|June 25, 2026
Landfill leakage location based on an induced polarization methodYayu Chen, Shibin Liu, Chaozhi Cai, et al.
International Journal of Molecular Sciences|October 30, 2016
Correction: Ping Meng, et al. Involvement of the Interleukin-23/Interleukin-17 Axis in Chronic Hepatitis C Virus Infection and Its Treatment Responses. Int. J. Mol. Sci. 2016, 17, 1070Ping Meng, Suxian Zhao, Xuemin Niu, et al.
Pageof 4